Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 36,666 shares at $54.92 ($2.0M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $2.0M DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.27 | 7,441 | $404K | 20.2% |
| 2 | $54.27 | 7,441 | $404K | 20.2% |
| 3 | $54.92 | 10,892 | $598K | 29.8% |
| 4 | $54.92 | 10,892 | $598K | 29.8% |
| Total | $54.66 avg | 36,666 | $2.0M | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |